Effects of H1-Antagonist on Cognition
NCT00846950
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Cognition
Interventions
DRUG:
dexchlorpheniramine, lorazepam
Sponsor
Maastricht University Medical Center